SLC10A1 and hepatocellular carcinoma: Nguyen et al. found that SLC10A1 expression is an independent predictor of survival outcome and recurrence-free survival, implying that SLC10A1 is a potential biomarker for early diagnosis and prognosis of HCC in the era of personalized medicine [26].